Xenomorph, the leading analytics and data management solution provider to global financial markets, has today announced that founder director and CEO Brian Sentance has moved to New York to spearhead the company’s North American growth and further boost its presence in the market.
The company, which first opened a sales and support operation in North America in 2005 with the launch of the New York subsidiary, has seen a dramatic acceleration in its US operations.
Naj Alavi, MD Americas, says: “The financial crisis has brought to the fore the issue of data quality to support risk management and market data analysis. This increased focus on data at both buy side and sell side institutions has led to good sales growth over the past year.”
“Our NY office has done an excellent job progressing sales and assisting our new clients in solving their risk management, backtesting and valuation needs” says Sentance. “We look forward to continuing this support and furthering our expansion into the data management space in North America”.
“Driven by regulatory changes and a demand for greater transparency, financial institutions are looking for future-proof, high performance systems which can scale with business needs and manage data analysis across front, middle and back offices.” adds Sentance. “We believe there is much more to achieve in this area and that Xenomorph is well positioned to meet the pressing needs of the US market.”
Brian Sentance will continue with his role setting company strategy, with the additional responsibility of directing marketing efforts, and will be joining co-founder and Consultancy Director Mark Woodgate in New York. Matthew Skinner takes over as Managing Director for Europe, with Naj Alavi continuing as Managing Director for the Americas.
